设为首页 电子邮箱 联系我们

本刊最新招聘信息请见“通知公告”!  本刊投稿系统试运行中,欢迎投稿!如投稿有问题,可直接将稿件发送至zgyy8888@163.com

 

主管单位:中华人民共和国   

国家卫生健康委员会

主办单位:中国医师协会
总编辑:
杨秋

编辑部主任:吴翔宇

邮发代号:80-528
定价:28.00元
全年:336.00元
Email:zgyy8888@163.com
电话(传真):010-64428528;
010-64456116(总编室)

                  

过刊目录

2021 年第 8 期 第 16 卷

肿瘤恶性增殖及侵袭相关基因在乳腺癌组织中表达水平与前哨淋巴结阳性数相关性分析

Correlation between expressions of tumor malignant proliferation and invasion-related genes in breast cancer tissues and positive number of sentinel lymph nodes

作者:江宁祥1曹迪2李振宇1陈映1许瑞庭1

英文作者:Jiang Ningxiang1 Cao Di2 Li Zhenyu1 Chen Ying1 Xu Ruiting1

单位:1西北民族大学第一附属医院宁夏回族自治区人民医院甲状腺乳腺科,银川750001;2宁夏回族自治区妇幼保健院中医科,银川750001

英文单位:1Department of Thyroid and Mammary Gland the First Affiliated Hospital of Northwest Minzu University People′s Hospital of Ningxia Hui Autonomous Region Yinchuan 750001 China; 2Department of Chinese Medicine Ningxia Hui Autonomous Region Maternal and Child Health Hospital Yinchuan 750001 China

关键词:乳腺癌;肿瘤恶性增殖;侵袭;前哨淋巴结

英文关键词:Breastcancer;Tumormalignantproliferation;Invasion;Sentinellymphnodes

  • 摘要:
  • 目的 研究肿瘤恶性增殖及侵袭相关基因在乳腺癌组织中表达水平与前哨淋巴结(SLN)阳性数的相关性。方法 选取20181月至201912月西北民族大学第一附属医院收治的乳腺癌患者80例,根据SLN病理诊断结果,将患者分为SLN阳性组和SLN阴性组,各40例。检测2组乳腺癌组织及SLN阳性组患者癌旁组织中肿瘤恶性增殖及侵袭相关基因mRNA表达量,并分析其与SLN阳性数的相关性。结果 SLN阳性组癌组织中张力蛋白mRNA表达量低于SLN阴性组和癌旁组织,磷脂酰肌醇-3-激酶(PI3K)、细胞周期蛋白D1及蛋白激酶BAKT mRNA表达量均高于SLN阴性组和癌旁组织[(0.48±0.07)比(1.39±0.22)、(0.81±0.13),(1.82±0.44)比(0.92±0.14)、(1.01±0.19),(1.72±0.34)比(0.12±0.10)、(0.67±0.21),(2.04±0.37)比(0.81±0.19)、(1.04±0.23)](均P0.05)。SLN阳性组癌组织中E钙黏蛋白mRNA表达量低于SLN阴性组和癌旁组织,N钙黏蛋白、β连环蛋白及转化生长因子β(TGF-β)mRNA表达量高于SLN阴性组和癌旁组织(均P0.05)。Pearson相关性分析显示,细胞周期蛋白D1PI3KAKTN钙黏蛋白、β连环蛋白及TGF-β mRNA表达量与SLN阳性数呈正相关,张力蛋白、E钙黏蛋白mRNA表达量与SLN阳性数呈负相关(均P0.05)。多因素Logistic回归分析结果显示,张力蛋白、PI3KAKTSLN阳性数的独立预测因子(均P<0.05)。结论 肿瘤恶性增殖及侵袭相关基因mRNA表达量与SLN阳性数相关,且张力蛋白、PI3K以及AKTSLN阳性数的独立预测因素。

  • Objective To investigate the correlation between expressions of tumor malignant proliferation and invasion-related genes in breast cancer tissues and positive number of sentinel lymph nodes(SLN). Methods From January 2018 to December 2019, 80 patients with breast cancer who admitted to the First Affiliated Hospital of Northwest Minzu University were enrolled. According to SLN pathological diagnosis results, they were divided into the SLN-positive group and SLN-negative group, with 40 cases in each group. The expressions of tumor malignant proliferation and invasion-related genes mRNA in breast cancer tissues of both groups and in para-cancerous tissue of SLN-positive group were detected. The correlation between the expressions and positive number of SLN were analyzed. Results The expression of phosphoatase and tensin homolog(PTEN) mRNA in cancerous tissue of SLN-positive group was lower than that in SLN-negative group and para-cancerous tissue, and the expressions of phosphatidylinositol 3-kinase(PI3K), cyclin D1 and protein kinase B(AKT) mRNA in cancerous tissue of SLN-positive group were higher than those in SLN-negative group and para-cancerous tissue [(0.48±0.07 vs 1.39±0.22,0.81±0.13;1.82±0.44 vs 0.92±0.14,1.01±0.19;1.72±0.34 vs 0.12±0.10,0.67±0.21;2.04±0.37 vs 0.81±0.19,1.04±0.23)](all P<0.05). The expression of E-cadherin mRNA in cancerous tissue of SLN-positive group was lower than that in SLN-negative group and para-cancerous tissue, and the expressions of N-cadherin, β-catenin and transforming growth factor-β(TGF-β) mRNA in cancerous tissue of SLN-positive group were higher than those in SLN-positive group and para-cancerous tissue (all P<0.05). Pearson correlated analysis showed that the expressions of cyclin D1, PI3K, AKT, N-cadherin, β-catenin and TGF-β mRNA were positively correlated with SLN positive number, and the expressions of PTEN and E-cadherin were negatively correlated with SLN positive number (all P<0.05). Multivariate Logistic regression analysis showed that PTEN, PI3K and AKT were independent predictors of SLN positive number (all P<0.05). Conclusion s The expressions of tumor malignant proliferation and invasion-related genes are related to the SLN positive number. PTEN, PI3K and AKT are independent predictors of SLN positive number.

copyright 《中国医药》杂志编辑部
地址:北京市朝阳区安贞路2号首都医科大学附属北京安贞医院北楼二层
电话:010-64456116 传真:010-64428528 邮编:100029 Email: zgyy8888@163.com
网址:www.chinamedicinej.com 京ICP备2020043099号-3

当您在使用本网站投稿遇到困难时,请直接将稿件投送到编辑部邮箱zgyy8888@163.com。







安卓


苹果

关闭